TORONTO and GLIL YAM, Israel, Aug. 4, 2022
/PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IM
Cannabis") (CSE: IMCC) (NASDAQ: IMCC), a leading medical and
adult-use recreational cannabis company with operations in
Israel, Canada, and Germany, will report operational and financial
results for the second quarter ended June
30, 2022, on Monday, August 15,
2022 before market opens.
The Company will host a zoom web conference on the same day at
9:00a.m. ET to discuss the results,
followed by a question-and-answer session for the investment
community. Investors are invited to register by clicking here. All
relevant information will be sent upon registration.
If you are unable to join us live, a recording of the call will
be available on our website at https://investors.imcannabis.com/
within 24 hours after the call.
About IM Cannabis Corp.
IM Cannabis (NASDAQ: IMCC) (CSE: IMCC) is a leading
international cannabis company providing premium products to
medical patients and adult-use recreational consumers. IM Cannabis
is one of the very few companies with operations in Israel, Germany, and Canada, the three largest federally legal
markets. The ecosystem created through its international operations
leverages the Company's unique data-driven perspective and product
supply chain globally. With its commitment to responsible growth
and financial prudence, and the ability to operate within the
strictest regulatory environments, the Company has quickly become
one of the leading cultivators and distributors of high-quality
cannabis globally.
In Israel, the Company imports
and sells premium and ultra-premium medical cannabis, operating
retail pharmacies, online platforms, distribution centres and
logistical hubs through IMC Holdings Ltd. and its subsidiaries and
affiliates, which enable safe delivery and quality control
throughout the entire value chain. In Germany, the IM Cannabis ecosystem operates
through Adjupharm GmbH, where it also distributes cannabis to
pharmacies to medical cannabis patients. In Canada, IM Cannabis operates through Trichome
Financial Corp. and its subsidiaries TJAC and MYM, where it
cultivates and processes cannabis for the adult-use market at its
Ontario, Nova Scotia, and Quebec facilities under the WAGNERS and
Highland Grow brands.
Logo -
https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg
Company Contact:
Maya Lustig, Director Investor
& Public Relations
IM Cannabis
+972-54-677-8100
maya.l@imcannabis.com
View original
content:https://www.prnewswire.com/news-releases/im-cannabis-to-report-second-quarter-2022-financial-results-on-monday-august-15-at-900am-et-301599797.html
SOURCE IM Cannabis Corp.